OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Registration to our newsletter is FREE, Join today by entering your email below!

Tag Archives: cancer

Theragenics Corp. (NYSE: TGX) Weighing Takeover Offer from Juniper Investment Co.

Posted on May 13, 2013 by Editor

Shares of Theragenics Corp. (NYSE: TGX) climbed to a 52-week high of 2.15 today after the medical device company serving the surgical products and prostate cancer treatment markets issued a press release announcing that they had received a takeover offer … Continue reading →

Posted in Articles, NYSE | Tagged , , , , , , , | Leave a comment

Can Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) Advance Projects of Regen BioPharma to Clinical Trials?

Posted on May 6, 2013 by Editor

The massive trading volume that Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) has attracted over the past few months has taken even greater heights on Monday as the biotechnology company focused on the development of regenerative medicine therapies and tools to … Continue reading →

Posted in Uncategorized | Tagged , , , , , , | Leave a comment

Will Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) Ease Investor Concern with Reported Progress of Subsidiary?

Posted on April 5, 2013 by Editor

Few companies in the penny stock market have attracted the kind of attention that Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) has over the past week and on Friday that attention hit a new level with more than 121 million shares … Continue reading →

Posted in Uncategorized | Tagged , , , , , , | Leave a comment

As PDUFA Date Draws Near Investors Placing Bets on A.P. Pharma, Inc. (OTCBB: APPA)

Posted on March 13, 2013 by Editor

Back on January 30, 2013 A.P. Pharma, Inc. (OTCBB: APPA) was trading at a 52-week high of 0.8870 due in large part to speculation that their lead product candidate for the prevention of chemotherapy-induced nausea, APF530, would manage to navigate … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , | Leave a comment

Has too Much Gone Wrong for MultiCell Technologies, Inc. (PINKSHEETS: MCET) to Regain Footing?

Posted on February 22, 2013 by Editor

On Tuesday shares of MultiCell Technologies, Inc. (PINKSHEETS: MCET) opened at 0.0034, a nice jump from their previous close of 0.0020, but the day would offer even more surprises for shareholders as the biopharmaceutical company surged to a high of … Continue reading →

Posted in Uncategorized | Tagged , , , , , , | Leave a comment

Does Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) Have Any Plans to Turn Ideas into Reality?

Posted on January 11, 2013 by Editor

For a company that hasn’t issued a press release since April 30, 2012 there has been a tremendous amount of interest in Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) as the biotechnology company has seen massive trading volume and Friday has … Continue reading →

Posted in Uncategorized | Tagged , , , , , , | Leave a comment

Can Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) Advance Cancer Drug into Phase III Trial Following Internal Review?

Posted on January 7, 2013 by Editor

An internal review prompted by the discovery of vial coding discrepancies while preparing for an end of Phase II meeting with the FDA may have saved Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) as shares of the biopharmaceutical company that develops first-in-class … Continue reading →

Posted in Articles, NASDAQ | Tagged , , , , , , , | Leave a comment

Has A.P. Pharma, Inc. (OTCBB: APPA) Done Enough to Ease FDA Concerns Over Lead Drug Candidate?

Posted on December 31, 2012 by Editor

It is getting close to crunch time for A.P. Pharma, Inc. (OTCBB: APPA) as the specialty pharmaceutical company’s FDA assigned Prescription Drug User Fee Act (PDUFA) action date of March 27, 2013 is drawing near and the future of their … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , | Leave a comment

Can Inovio Pharmaceuticals, Inc. (AMEX: INO) Realize Potential with Multiple Synthetic Vaccines for Wide Range of Medical Issues?

Posted on November 28, 2012 by Editor

After starting the month of November strong with a share price that hit 0.7200 Inovio Pharmaceuticals, Inc. (AMEX: INO) hit a snag and slipped as low as 0.4400 but the biotechnology company has been posting some pretty impressive numbers of … Continue reading →

Posted in AMEX, Articles | Tagged , , , , , , , , , | Leave a comment

BSD Medical Corporation (NASDAQ: BSDM) Reports Significant Sales Spike but is it a Difference Maker?

Posted on October 9, 2012 by Editor

BSD Medical Corporation (NASDAQ: BSDM) delivered some positive news on Tuesday, announcing that they had seen a 391% increase in sales for their MicroThermX Microwave Ablation System product line for September 2012, as compared to September 2011 with their disposable … Continue reading →

Posted in Articles, NASDAQ | Tagged , , , , , , , , | Leave a comment